Иммунологические свойства опухолевых клеток, определяющие степень их злокачественности
Диссертация
Логично предположить, что, поскольку во взаимоотношениях хозяина и опухоли иммунологические свойства злокачественных клеток должны играть существенную роль, большое разнообразие в таких свойствах среди опухолевых клеток может обусловливать широкий спектр вышеупомянутых взаимоотношений. Иммуногенность (способность вызывать наработку цитотоксических и блокирующих антител, клеток эффекторов… Читать ещё >
Список литературы
- Абелев Г. И. Иммунология злокачественных опухолей. Вестн. Акад. Мед. наук СССР, 1974, № 2, с.23−29
- Алексанян Ю.Т., Басмаджян М. Е., Мовсесян К. С., Манукян Л. А., Геворкян С. А. Линия перевиваемых клеток, полученная из перевиваемой мышиной гепатомы. Бвшл.эксп.биол. и мед., 1972,1. В 5, с.94−95.
- Белохвостов А.С. Иммунодецрессивное действие опухоли. Вопросы онкологии, 1978, т.24, № 3, с.99−106
- Бернет Ф. Клеточная иммунология. М.: Мир, 1971, — 542 с.
- Билынский Б.Т., Шпарик Я. В. Естественные клетки-киллеры. -Воцросы онкологии, 1980, т.26, № 7, с.95−104
- Брондз Б.Д., Дризлих Г. И. Клеточные основы иммунологического распознавания. Антигенсвязывающие рецепторы Т лимфоцитов. -Молек.биол., 1977, т. II, № 2, с.253−285
- Брондз Б.Д., Караулов А. В., Абронина И. Ф. Иммунологическая специфичность и кинетика индукции Т-супрессоров при иммунизации мышей азшогенной селезенкой. Цитология, 1980, т.22, № 5, с.583−590
- Брондз Б.Д., Рохлин О. В. Молекулярные и клеточные основы иммунологического распознавания. М.: Наука, 1978. — 335 с.
- Быковская С.Н., Быковский А. Ф., Сергеев А. В., Луганская Л. И., Иванов А. А., Раушенбах М. О. Электронно-микроскопическое изучение взаимодействия цитолитических Т лимфоцитов и клеток мишеней. Бюлл. эксп. биол. и мед., 1977, т. 134, № 10,с.443−447
- Ю.Васильев Ю. М. Соединительная ткань и опухолевый рост в экс' перименте. М.: Медгиз, 1961, — 140 с. И. Васильев Ю. М., Гельфацц И. М. Взаимодействие нормальных и неопластических клеток со Средой. — М.: Наука, 1981. — 220 с.
- Вядро М.М. Роль макрофагов в противоопухолевом иммунитете. -Успехи совр. биологии, 1977, т.84, вып. 2, с.236−247
- Вядро М.М. Изучение цитотоксического действия активированных ЕЩК макрофагов на опухолевые клетки мишени. Бюлл. эксп. биол. и мед., 1969, т.137, JS I, с.36−39
- Гамбург В.П. Искусственная гетерогенизация опухолей. -Воцросы онкологии, 1976, т.22, № 7, с.103−111
- Георгиев Г. П. О механизме онкогенеза: «цромоторная» гипотеза. Молекулярная биология, 1981, т, 15, вып. 2, с. 261 273
- Глушакова Л.Г., Шуклинов В. А. Гибриды нормальных и злокачественных клеток. Вопросы онкологии, 1976, т. 22, 5, с. 97−105
- Говалло В.И. Иммунологические взаимоотношения организма и опухоли. Воцросы онкологии, 1975, с. 21, № 10, с. 93−102
- Говалло В.И. Иммунотерапия злокачественных опухолей человека. Вопросы онкологии, 1976, т.22, № 3, с. 99−109
- Горелик Л.С. Иммунологический надзор и канцерогенез. -Успехи совр. биол., 1975, т.80, вып. 2, с.270−280
- Грунтенко Е.В. Иммунологические аспекты злокачественного роста. Дис. докт. биол. наук. — Новосибирск, 1976 — 327 с.
- Грунтенко Е.В. Иммунитет и возникновение злокачественных опухолей. Новосибирск, Наука, 1977. — 271 с.
- Грех И.Ф. Рак и лимфатическая система. Вопросы онкологии, 1971, т.17, № 10, с I0I-II0
- Дейчман Г. И. Современные концепции иммунологических взаимоотношений опухоли и организма. «Опухолевый рост как проблема биологии развития». М.- Наука, 1979, с. 208−230
- Дятловская Э.В., Бергельсон Л. Д. Липиды опухолей и их влияние на структуру и функционирование клеточных мембран.
- Вестн. Ак. мед.наук СССР, 1982, № 3, с. 42−47
- Кавецкий Р.Е. Взаимодействие организма и опухолей. Киев: Наукова думка, 1977, — 235 с.
- Кравченко А.Т., Милютин В. Н., 1Удима О.С. Микрокиносъемка в биологии. М.: Медгиз, 1963. — 175 с.
- Красковский Г. В. Иммунологические основы раковой анергии. -Минск: Наука и техника, 1970. 245 с.
- Козлов A.M., Софьина З. П. Частота, сроки и тип метастазиро-вания различных перевиваемых опухолей мышей. Бюлл. эксп. биол. и мед., 1978, № 12, с. 715−718
- Лавровский В.А., Викслер В. Х. Увеличение скорости потери антител клетками мишенями под влиянием спленоцитов. -Цитология, 1978, т.20, & 6, с. 695−699
- Лавровский В.А., Викслер В. Х. Цитологические антитела в сыворотке мышей СЗН после прививки им клеток спотанной опухоли молочной железы. Журнал Микробиол., 1979, № 9, с. 5761
- Лавровский В.А., Викслер В. Х., Ибрагимов P.M. Иммунологические свойства злокачественной и незлокачественной сублиний клеток L . Сообщение 1У. Иммунный ответ у мышей СЗН. Журнал Микробиол., 1980, № 4, с.69−72
- Лавровский В.А., Викслер В. Х., Разворотнев В. А., Лобков Ю. И. Свойства клеток, определяющие их иммуночувствительность. -Цитология, 1977, т. 19, № 9, с. I018−1023
- Лавровский В.А., Викслер В. Х., Устинов А. С. Цитотоксические антитела против клеток опухолей в крови интактных мышей линии СЗН. Бюлл. эксп. биол. и мед., 1979, т. 137, № 5,с 460−462
- Лавровский В.А., Викслер В. Х., Юрченко Ю. А., Разворотнев В. А. Генетическая детерминированность иммунного ответа мышей наклетки разного гистологического типа. Генетика, 1978, т.14, № I, с. 72−79
- Лавровский В.А., Ибрагимов P.M., Викслер В. Х. Натуральная киллерная активность спленоцитов крыс in vitro . Блокирующее влияние гомологической сыворотки. Журнал Микробиол., 1981, № II, с. 62−67
- Лавровский В.А., Разворотнев В. А. Возможность использования облученных неделящихся клеток мишеней цри оценке цито-литической активности лейкоцитов in vitro. Цитология, 1975, т. 17, & II, с. I3I3-I3I6
- Лавровский В.А., Разворотнев В. А. Влияние сыворотки крупного рогатого скота и мышей на цитопатогенную реакцию лейкоцитов in vitro . Изв. Акад. наук СССР, Серия биологическая, 1977, № 2, с. 251−257
- Лазарев Н.И., Шароухова К. С., Гончарова М. Г., Панов М. А., Самойлов В. И. Механизмы противоопухолевого действия гормонов. М.: Медгиз, 1974. — 168 с.
- Лобко Г. Н., Порубова Г. М. Имцуногенетические основы резистентности опухолей. Минск: Высшая школа, 1980, — 176 с.
- Любимов А.В. Поверхностные белки клеток и их изменения цри нормальном развитии и опухолевом росте. В кн.: Явление индукции и дифференцировка. М., Наука, 1981, с. I7I-25I
- Матэ Ж. Активная иммунотерапия рака, иммунопрофилактика и иммунореабилитация. М.: Медицина, 1980. — 424 с.
- Медуницин Н.В. Фактор торможения миграции макрофагов. -Успехи совр. биологии, 1977, т. 84, вып. 2, с. 248−256
- Методы изучения in vitro клеточного иммунитета. М.: Медицина, 1974. — 403 с.
- Мосолов А.Н. Камера для постоянного наблюдения и микрокиносъемки культуры ткани. Вопросы вирусологии, 1961, т. 6, с. 748−750
- Оленов Ю.М. Гипотеза регрессивной эволюции опухолевых клеток. Цитология, 1962, № 4, с. 251−268
- Петров Р.В. Иммунология и иммуногенетика. М.: Медицина, 1976. — 356 с.
- Пол Д. Культура клеток и тканей. М.: Медгиз, 1963, — 347с.
- Погосянц Е.Е. Новое в цитогенетике рака. Генетика, 1981, т. ХУЛ, № 12, с. 2087−2099
- Разворотнев В.А., Лавровский В. А., Викслер В. Х. Выделение опухолевыми и неопухолевыми клетками веществ, модифицирующих миграцию макрофагов и цитопатогенное действие иммунных лимфоцитов in vitro . Журнал Микробиол., 1977, № 6, с. 4851
- Роничевская Г. М. Проблемы цитогенетики злокачественного роста. Новосибщюк: Наука, 1977. — 188 с.
- Салямон Л.С. Анализ опухолевой трансформации ткани. I. Признаки автономности и их возникновение. Цитология, 1969, т. II, J6 I, с. 1366−1378
- Снелл Д., Доссе Ж., Нэтенсон С. Совместимость тканей. М.: Мир, 1979. — 501 с.
- Ставровская А.А. Некоторые аспекты генетики опухолевой клетки. В кн.: Опухолевой рост как проблема биологии развития. М., Наука, 1979, с. 82−108
- Уманский Ю.А., Пинчук В. Т. Лимфоциты и опухолевый рост. Киев: Наукова думка, 1982, 256 с.
- Шапиро Н.И. Генетические механизмы канцерогенеза. Вестник АН СССР, 1981,? 12, с. 69−75
- Шапот B.C., Миронов Н. М. Нестабильность генома и неоплазия.-Цитология и генетика, 1981, т. 15, 6, с 73−83
- Шапот B.C. Биохмические аспекты опухолевого роста. М.: Медицина, 1975. 304 с.
- Швембергер И.Н. Рак и дифференцировка клетки. -Л.: Наука, 1976. 160 с.
- Фель В.Я. Нарушение цитодифференцировки при малигнизации и проблема иммунного надзора. Л.: Наука, 1977. — 184 с.
- Хаитов P.M., Батырбеков А. А. Коррекция иммунного ответак эритроцитам барана у мышей разных линий с помошью полиэлектролитов. Бюлл. эксп. биол. и мед., 1976, т. 81, № 5, с. 582−584
- Хестон В. Опухоли молочной железы у мышей, лишенных фактора молока. В кн.: Генетика рака, м., 1961, с. 155−168
- Хунданова Л.И., Хунданов Л. Л. Иммунология канцерогенеза. -М.: Наука, 1978. 208 с.
- Alois U, Christopher В, P., Jonathan G, Craig K, Dual effects of tumor antigens: induction of tumor resistance or tumor growth enhancement. Ann, N.Y. Acad, Sci., 1976, v. 276, p.106−123.
- Aoki Т., Chieco-Bianchi L, Plata E. J, Sendo P., Hollis V.W., Kudo T, Host immune response to virus-induced tu -mors. Immunology of cancer progr. exp, tumor res., 1974″ v. 19, P. 23−36.
- Argyris B, P, DeLustro. Immunologic unresponsiveness of mouse spleen sensitized to allogenic tumors. Cell Immunol., 1977, v.28, No. 2, p.390−403.
- Arnand-Battandier P., Bundy Bonita Ш., Nelson D.L. Natural killer cells in guinea pig spleen bear Pc receptors. Eur. J. Immunol., 1978, v.8, p. 400−406.
- Arthur L.O., Pine D. L, Naturally occurring humoral immunity to murine mammary tumor virus (Mu MTV) and MuMTV Gp 52 in mice with low mammary tumor incidence.- Int. J. Cancer, 1978, v.22, No.6, p.734−740.
- Auerbach R., Morrisey L.W., Sidky Y, A. Regional differences in the incidence and growth of mouse tumors following intradermal or subcutaneous. Cancer Res., 1978, v.38, No.6, p.1729−1744.
- Baldwin R.W., Pimm M.V. B.C.G, immunotherapy of a rat sarcoma. -Br, J. Cancer, 1973, v.28, No.4, p.281−287.
- Banerjee D.N., Banerjee M.R., Metha R.G. Hormonal regulation of rapidly labelled RNA in normal preneoplastic and neoplastic tissues of mouse mammary gland.- J. Natl. Cancer Inst., 1973, v.51, No.3, p.843−849.
- Barna В., Deodhar S.D. The activity of gerional nodes in the evolution of immune responses to allogenic and isoge- 234 neic tumors.- Cancer Res., 1975, v.35, p.920−926.
- Barrett J.C., Tso P.O.P. Evidence for the progressive nature of neoplastic transformation in vitro.- Proc. Natl. Acad. Sci. U.S.A., 1978, v. 75, Ho.8, p.3761−3765.
- Bartholomaeus W.N., Bray A.E., Papadimitriou J.M., Keast D. Immune response to a transplantable malignant melanoma in mice.- J. Natl. Cancer Inst., 1974, v.53, No.4, p. 10 651 072.
- Barthdomew R#M., Esser A.F., Muller-Eberhard H.J. Lysis of oncornaviruses by human serum. Isolation of the viral complement (C1) receptor and identification as p15E.
- J, Exptl. Med., 1978, v.147, No.3, p.844−853.
- Basomobrio M.A., Prehn R.T. Immune Status of autochtonous and adoptively protected mice toward spontaneous and chemically induced tumors.- Cancer Res., 1972, v.32, No.11, p.2445−2550.
- Belyaev D. H#, Gruntenko E.V. The influence of the thymus on the development of transplanted mammary tumor in mice. Int. J. Cancer, 1972, v.9, No.1, p.1−7.
- Benacerraf В., Katz D.H. The histocompatibility-linked immune response genes.- Advances in Cancer Res., 1975, v.21, p.121−173.
- Bentvelzen P. Host-virus interactions in murine mammary carcinogenes.- Biochem. et Biophys. Acta, 1974, v.355, p.236−259.
- Berendt M.J., North R.J. T-cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenic tumor.- J. Exptl. Med., 1980, v. 151, No.1, p.69−80.
- Berg J.W. Morphological evidence for immune response tobreast cancer. A historical review. Cancer, 1971, v.28, No. 6, p. 1453−1456.
- Berger A.E., Amos D.B. A comparison of aniibody-depen-dent cellular cytotoxicity (ADCC) mediated by murine and human lymphoid cell populations. Cell Immunol., 1977, v. 33, No. 2, p. 277−290.
- Berke G., Fishelson Z. T-lymphocyte-mediated cytolisis: contribution of intracellular components to target cell susceptibility. Transpl. Proc., 1977, v. 9, No. 1, p. 671−674.
- Bernstein J.D., Thor D.E., Zbar В., Rapp H.J. Tumor immunity: tumor suppression in vivo initiated by soluble products of specifically stimulated lymphocytes. Science, 1971, v. 172, No. 3984, p. 729−731.
- Betton G.R., Gorman N.T. Cell-mediated responses in dogs with spontaneous neoplasms. I. Detection of cell-mediated cytotoxicity by the chromium-S1 release assay. J. Natl. Cancer Inst., 1978, v. 61, No. 4, p.1085−1093.
- Biddison W.E., Palmer J.C. Development of tumor cell resistance to syngeneic cell-mediated cytotoxicity during growth of ascitic mastocytoma P81SY. Proc. Natl.Acad. Sci. USA, 1977, v.74, No. 1, p.329−333.
- Birke Ch., Peter H.H., Langenberg G.R. Mycoplasma contamination in human tumor cell lines: effect on interfe -ron induction and susceptibility to natural killer.- J. Immunol., 1981, v. 127, No. 1, p. 94−98.
- Black M.M., Zachrau R.E., Dion A.S., Shore В., Pine D.L., Leis H.P., Williams C.J. Cellular hypersensitivity togp 55 of R III-murine mammary tumor virus and gp 55 like protein of human breast cancers.- Cancer Res., 1976, v.36, No.11, p.4137−4142.
- Blair P.B. Immunologic aspects of the relationship between host and oncogenic virus in the mouse mammary tumor system.- Israel J. Med. Science, v.1971, v.7, p.161−182.
- Blair P.B. Immunologic aspects of tumor induction by mammary tumor virus.- J. Natl. Cancer Inst., 1972, v.48, N0.4, p.1121−1124.
- Blair P.B. Natural Immunity in the oncorna-virus-injected mouse.- Cancer Res., 1976, v.36, p.734−738.
- Blair P.B., Lane M.A. Serum factors in mammary reoplasma: enhancement and antagonism of spleen cell activity in vitro directed Ъу different methods of serum factor assay.- J. Immunol., 1974, v.112, No.2, p.439−443.
- Blair P.B., Lane M.A. In vitro detection of immune responses to MTV-induced mammary tumors: qualitative differences in response directed by time studies.- J. Immunol., 1975, v.114, No.1, p.17−23.
- Blair P.B., Lane M.L. Early detected of tumor-specific antibodies to mammary carcinoma.- Int. J. Cancer, 1978, v.21, N0.4, p.476−481.
- Blair P.B., Lane M., Mar P. Complexity of factors in sera of different mice that affect MTV-induced mammary tumor cells.- J. Immunol., 1976, v.116, No.3, p.610−614.
- Blasecki J.W., Tevethia S.S. Restoration of specific immunity against SV40 tumor-specific transplantation antigen to lymphoid cells from tumor-bearing mice.- Int. J, Cancer, v.16, p.275−283.
- Blazar B.A., Miller F.R., Heppner G.H. In situ lymphoid cells of mouse mammary tumors. III. In vitro stimulationof tumor survival by lymphoid cells separated from mammary tumors.- J, Immunol., 1978, v.120, No.6, p.1887−1891.
- Bluming A.Z., Yogel C.V., Zuegler J.L., Kiryabnire J.W.M. Delayed cutaneous sensitivity reactions to extracts of autologous malignant melanoma: a second look.- J.Natl. Cancer Inst., 1972, v.48, No, 1, p.17−24.
- Bonmassar В., Bonmassar A., Goldin A., Cudkowicz G. Depression of antilymphoma allograft reactivity by tumor-associated factors.- Cancer Res., 1973, v.33″ No.5, p. 1054−1061.
- Boraschi D., Meltzer M.S. Macrophage activation for tumor cytotoxicity: genetic variation in macrophage tumori-cidal capacity among mouse strains.- Cell Immunol., 1979, v.45, No.1, p.188−194.
- Broder S., Maul L., Waldmann T.A. Supressor cells in neoplastic deasese.- J. Natl. Cancer Inst., 1978, v.61, No.1, p.5−11.
- Bronz B.D. Interaction on immune lymphocytes in vitro with normal and neoplastic tissue cells.- Folia Biol.: Praga, 1964, v.10, No.4, p.163−176.
- Brooks W.H., Netsky M.G., Normansell D.E., Norwitz D.A. Depressed cell-mediated immunity in patients with primary intracranial tumors. Characterization of a humoral immunosuppressive factor.- J. Exptl. Med., 1972, v.136,1. No.6, p.1631−1647.
- Вгштег К.Г., Mauel J., Rudolf H., Chapius B. Studies of allograft immunity in mice. Induction, development and in vitro assay of cellular immunity.- Immunology, 1970, v.18, p.501−515.
- Bullough W.S., Hewett C.L., Laurence E.B. The epidermal chalone: A preliminary attempt at isolation.- Exptl. Cell Res., 1964, v.36, p.192−200.
- Canty T. G, Wunderlich J.R., Fletcher P. Qualitative and quantitative studies of cytotoxic immune cells, — J. Immunol., 1971, V.106, p.200−208.
- Carnaud C, Hoch В., Trainin N. Influence of immunologic competence of the host on metastases induced by the 311 Leuis tumor in mice.- J. Natl, Cancer Inst., 1974″ v.32, N0.8, p.395−399.
- Cerottini J., Brunner K.T. Cell-mediated cytotoxicityallograft rejection and tumor immunity.- Advances in Immunol., 1974, v. 18, p.67−132.
- Chandradasa R.D. The development and specific suppression of concomitant immunity in two syngeneic tumour-host systems.- Int. J. Cancer, 1973, v. 11, Ho. 3, p. 648−662.
- Cheema A.R., Hersh E.M. Patient survival after chemotherapy and its relationship to in vitro lymphocyte blasto-genesis.- Cancer, 1971, v. 28, No. 4, p. 851−855.
- Chen T.R. In situ detection of Mycoplasma contamination in cell cultures by fluorescetn hoechst 33 258 strain.-Exptl. cell Res., 1977, v. 104, No. 2, p. 255−264.
- Cheung H.T., Cantarow W.D., Sundharadas G. Characteristics of a low-molecular-weight factor extracted from mouse tumors that effects in vitro properties of macrophages.- Int. J. Cancer, 1979, v. 23, No. 3, p. 344−352.
- Cikes M., Friberg S., Klein G. Progressive loss of H-2 antigens with concomitant increase of cell-surface antigen (s) determined by Moloney leukemia virus in culturedmurine lymphomas. J. Nat. Cancer Inst., 1973, v. 50, No. 2, p. 347−362.
- Codington J.P., Klein G., Cooper G.G., Lee N., 'Brown M. C., Roger W. Further studies on the relationship between large glycoprotein molecules and allotransplantability in the ТАЗ tumor of the mouse: studies on segregating
- ТАЗ-Ha hybrids.- J.Natl. Cancer Inst., 1978, v. 60, No. 4, p. 811−818.
- Codington J.F., Sanford B.H., Jeanloz R.W. Cell-surface Glycoproteins of tv/o subleines of the ТАЗ tumor.-J.Natl. Cancer Inst., 1973, v. 51, No. 2, p. 585−591.
- Cohen A.M., Burdick J.P. and Ketcham A.S. Cell-mediated125cytotoxicity: an assay using J-iododeoxyuridine-labe-led target cells. J. Immunol., 1971, v. 107, p.895−898.
- Cohen J.M., Law L. W, Spontaneous disappearance of tumori-genicity in a Polyoma virus-induced neoplasmarried in vitro. Proc.Soc. Exp. Biol. Med., 1974, v. 145, No. 2,1. P. 385−388.
- Collins J.L., Patek P.E., Cohn M. Tumorigenicity and lysis by natural killers.-J. Exp. Med., 1981, v. 153, No.1,p. 89−106.
- Collins J.J., Rolanson G., Haagensen D.E., Pischinger P. J., Wells S.A., Holder W., Bolognesi D.P. Immunologic control of the oscites form of murine adenocarcinoma 755 II Tumor immunity associated with a Priend-Moloney
- Rauscher-type virus.- J. Natl. Cancer Inst., 1978, v. 60, No. 1, p. 141−152.
- Cooper A.G., Codington J.F., Brown M.G. In vivo release of glycoprotein I from the Ha subline of ТА 3 murine tumor into ascites fluid and serum. Proc.Natl.Acad. Sci., USA, 1974, v. 71, No. 4, p. 1224−1228.
- Cooper A.G., Codington J.F., Miller D.R., Brown M.C. Loss of strain specificity of the TA3-St subline: evidence for the role of epiglycanin in mouse allogenic tumor growth. J. Natl, Cancer Inst., 1979, v. 63, No. 1, p. 163−169.
- Gudkowicz G, Yung J. P, Abrogation of resistance to foreign bone marrow grafts by carrgeenans. I. Studies with the anti-macrophage agent seakem carrgeenan.- J. Immunol., 1977, v. 119, No. 2, p. 483−487.
- Currie G. Immunological aspects of host resistance to the development and growth of cancer.- Biochem. et Bio-phys. Acta, 1976, v. 458, p. 135−165.
- Daynes R. A, Schmitt M, K., Roberts L.K., Spellman C. W, Phenotypic and physical characteristics of the lymphoid cells involved in the immunity to syngeneic UV-in-duced tumors.- J. Immunol., 1979, v. 122, No. 6, p.2458−2464.
- Deichman G.J., Kluchareva Т.Е., Kashkina L.M., Matvee-va V.A. Reproducibility and relation to specific and nonspecific anti-tumor resistance of the tumor «sneaking through» phenomenon.- Int. J. Cancer, 1979, v.23, No. 4, P. 571−584.
- Devens В., Galili N., Deutsch 0., Naor D., Klein E. Immune responses to weakly immunogenic virally inducedtumors. Ila suppressive effects of the in vivo carried tumor JAG.- Eur. J. Immunol., 1978, v.8, No.8, p.573−578.
- Devens В., Schochot L., Naor D# Immune responses toweakly immunogenic virally induced tumors. V. Short in vitro cultivation of JAC changes its antigenic properties.- Cell Immunol., 1979, v.44, No.2, p.442−453.
- Droller M.J., Schneider M.U., Perlman P. A positiverole of prostaglandins in the inhibition of natural and antibody-dependent cell-mediated cytotoxicity against tumor cells.- Cell Immunol., 1978, v.39, No.1, p.165−177.
- Dullens H.E.J., Otter W.D. Therapy with allogeneic immune peritoneal cells.- Cancer Res., 19 745 v.34, p.1726−1730.
- Dunlop M.B.C., Morse H.C., Graff R.J. The cytotoxic T-cell response to H-1 minor histocompatibility antigen differences.- Cell Immunol., 1980, v.50, No.1, p.169−176.
- Eggers A.E. Immune response to allogeneic progressively growing solid tumor.- Cancer Res., 1976, v.36, No.6,p.2085−2089.
- Eremin 0., Ashby J., Stephens J.P. Human natural cytotoxicity in the blood and lymphoid organs of healthy donors and patients with malignant disease.- Int. J.
- Cancer, 1978, v.21, No.1, p.35−41.
- Esmon N, L., Little J.R. Different mechanisms for the modulation of TL antigens on murine lymphoid cells.-J. Immunol., 1976, v.117, No.3, p.919−926.
- Evans R., Alexander P. Role of macrophages in tumor immunity. I, Cooperation between macrophages and lymphoid cells in syngeneic tumor immunity.- Immunology, 1972, v.23, No.4, p.615−626.
- Fauve R.M., Hevin В., Jacob H., Gaillard J.A., Jacob F. Antiinflamatory effects of murine malignant cells. -Proc. Nat. Acad. Sci. USA, 1974, v.71, No.10,p.4052−4056.
- Fenjo B.M., Klein E., .Klein .G., Swiech K. Selection of an immunoresistant Moloney lymphonoma subline with decreased concentration of tumor-specific surface antigens.- J. Nat. Cancer Inst., 1968, v.40, No.1,p.69−89.
- Fidler J.J. Recognotion and destruction of target cells tumoricidal macrophages.- Israel J. Med. Sci., 1978, v.14, No.1, p.177−191.
- Fidler J.J., Bucana C. Mechanism of tumor cell resistance to lysis by syngeneic lymphocytes.- Cancer Res., 1977, v.37, No.11, 3945−3956.
- Fidler J.J., Nicolson G.L. Tumor cell and host properties affecting the implantation and survival of blood-borne metastatic variants of B16 melanoma.- Israel J. Med. Sci., 1978, v.14, No.1, p.38−50.
- Fishelson Z., Berke G. T lymphocyte-mediated cytolysis: dissociation of the binding and lytic mechanisms of the effector cell.- J. Immunol., 1978, v.120, No.4,p.11 211 126.
- Fisher В., Saffer E.A. Tumor cell cytotoxicity by granulocytes from peripheral blood of tumor-bearing mice.-J. Natl. Cancer Inst., 1978, v.60, No.3, p.687−691.
- Fisher В., Saffer E.A., Fisher E.R. Studies concerning the regional lymph node in cancer. IV. Tumor inhibition by regional lymph node cells.- Cancer, 1974, v.33, No.3, p.631−636.
- Foulds L. Multiple etiologic factors in neoplastic development.- Cancer Res., 1965, v.25, No.8, p.1339−1351.
- Fox R.R., Cherry M. Effect of rabbity strain on activity level and cytotoxicity of serum complement. II. Comparison of five murine target cells. J. Heredity, 1978, v.69, No.5, p. 331−336.
- Friberg S. Comparison of an immunoresistant and an immuno-susceptible ascites. I. Transplantability, morphology and some physicochemical characteristics.- J, Natl*Cancer Inst, 1972a, v.48, No.5, p.1463−1476.
- Froese G., Berczi J., Sehon Neuraminidase-induced enhancement of tumor growth in mice.- J. Nat. Cancer Inst., 1974, v.52f-No.6, 1905−1908.
- Fujimoto S., Green M.J., Sephon A.H. Regulation of the immune response to tumor antigens.- J. Immunol., 1976, v.116, No.3, p.791−799.
- Fujiwara H., Hamaoka Т., Teshima K., Aoki H., Kitagawa M. Preferential generation of killer or helper T-lym-phocyte activity directed to the tumor associated transplantation antigens.- Immunology, 1976, v.31″ No.2,p.239−248.
- Gautam S.C., Deodhar S.D. Presence of suppressor cells in spleens of mice bearing a weakly immunogenic syngeneic tumor.- Cancer Res., 1979, v.39, N0.8, p.2945−2951.
- Gebhard B.M. Mixed lymphocyte reactions: absence of stimulation by irradiated allogeneic cells.- Cell Immunol., 1973, v.8, No.2, p.290−298.
- George M., Yaughan J.H. In vitro cell migration as a model for delayed hypersensitivity.- Proc. Soc.Exptl. Biol. Med., 1962, No.2, p.514−521.
- Gerlier D., Price M., Baldwin R.W. Non-immunogenicity of enucleated rat hepatoma cells in syngeneic animals. -Br. J. Cancer, 1981, v.44, p.725−732.
- Gershon R.K., Carter R.L. Factors controlling concomitantimmunity in tumor-bearing hamster: effects of prior splenectomy and tumor removal, — J, Nat, Cancer Inst., 1969, v.43, No.3, p.533−543.
- Gershon R.K., Kondo R. Mechanism by which the spleen may act in regulating tumor immunity after tumor resection.- J. Nat. Cancer Inst., 1969, v.43,p.545−551.
- Ghose Т., Guclu A., Faulkner J., Tai. In vivo suppression of El-4 lymphoma by rabbit anti-tumor sera.- J. Natl. Cancer Inst., 1977, v.58, No.3, p.693−700.
- Gillespie G.L., Barth R.F. Cyclic variations in cell-mediated immunity skin allografts detected by the tech-netium-99 microcytotoxicity assay.- Cell Immunol., 1974, v.13, p.472−483.
- Gillespie G.V., Russel S.W. Development and resistance of cytolytic T-lymphocytes in regression or progressing Moloney sarcomas.- Int. J. Cancer, 1978, v.21, No.1,p.94−99.
- Gillette R.W., Berringer D.C., Wunderlich D.A. Resistance to syngeneic lymphoma cells as a result of immunization with chemically modified allogeneic lymphoma cells in mice.- J. Nat. Cancer Inst., 1978, v.60,No.6, p.1427−1432.
- Gillette R.W., Fox A. The effect of T lymphocyte deficiency on tumor induction and growth.- Cell Immunol., 1975, v.19, N0.2, p.328−335.
- Gillette R. W, Lowery L.T. Virus-dependent cytostatic activity to mammary tumor cells of lymphocytes from normal mice.- Cancer Res., 1976, v.36, No.11, p.4008−4014.
- Goldberg L.S., Lonie J.S., Baker M.H. Inhibition ofmacrophage migration: a test system using human mono-cysts.- J. Immunol., 1971, v.107, No.3, p.906−909.
- Golstein P., Poa G., MacLennan J. Mechanism of T cell-mediated cytolysis: the differential impact of cytochala-sins at the recognition and lethal hit stages.- Eur. J. Immunol., 1978, v.8, No.5, p.302−309.
- Good R.A. Relations between immunity and malignancy,-Proc. Nat. Acad. Sci. U.S.A., 1972, v.69, No.4, p.1026−1032.
- Gorczynski R.M. Evidence for in vivo protection against murone-sarcoma virus-induced tumors by T lymphocytes from immune animals.- J. Immunol., 1974, v.112, No.2, p. 533- 539.
- Gorelik E#, Wiltrout R.H., Okumura K., Habu S., Herberman R.B. Role of Ж cells in the control of metastatic spread and growth of tumor cells in mice.- Int. J. Cancer, 1982, v.30, No.1, 107−112.
- Gorelik E, Segal S, Peldman M. Growth of a local tumor exerts a specific inhibitory effect on progression of lung metastases.- Int. J, Cancer, 1978, v.21, No.5, p. 617−625.
- I) IU dR growth inhibition assay.- Immunology, 1975, v.29, p.719−729,
- Gresser J., Yignaux P., Maury C., Lindahl P. Pactor (s) from Ehrlich ascites cells responsible for delayed rejection of skin allografts in mice and its assay on lymphocytes in vitro (38 748).- Proc. Soc. Exptl. Biol. Med., 1975, v.149, No.1, p.83−88.
- Gronberg A., Hans son M., Kiessling R., Andersson B., Ka-rre K., Roder J. Demonstration of natural antibodies in normal rabbit serum with similar specificity pattern as mouse natural killer cells. J. Nat. Cancer Inst., 1980., v.64, No.5, p.1113−1119.
- Gullino p.M., Grantham P.H., Losonczy L., Berghoffer B. Mammary tumor regression. I. Physiopathologic characteristics of hormone-dependent tissue.- J. Natl. Cancer Inst., 1972, v.49, No.5, p.1333−1348.
- Hakomori S, Structures and organisation of cell surface glycolipids dependency on cell growth and malignant transformation.- Biochem. Biophys. Acta, 1975, v.417, No.1,p.55−89.
- Haller 0. Mouse natural cell-mediated cytotoxicity to human leukemia: independence of source used for target-cell culturing and cytotoxicity assay.- J. Natl. Cancer Inst., 1978, v.60, No.5, p.1433−1438.
- Haller 0., Hansson M., Kiessling R., Wigzell H. Role of non-conventional natural killer cells in resistance against syngeneic tumor cells in vivo.- Nature, 1977, v. 270, No.5638, p.609−611.
- Haller 0., Kiessling R., Orn A, Karre K., Hilsson K., Wigzell H. Natural Cytotoxicity to human leukemia mediated by mouse non-T cells.- Int. J. Cancer, 1977, v.20, No.1, p.93−103.
- Halliday W.J., Miller S. Leukocyte adherence inhibition: a simple test for cell-mediated tumor immunity and. serumblocking factors.- Int. J. Cancer, 1972, v.9, No.3, p.477−483.
- Hanna N., Fidler I.J. Relationship between metastatic potential and resistance to natural killer cell-mediated cytotoxicity in three murine tumor systems.- J. Natl. Cancer Inst., 1981, v.66, No.6, 1183−1190.
- Hanna M.G., Zbar В., Rapp H.J. Histopathology of tumor regression after intralesional injection of Mycobacterium bovis. I. Tumor growth and metastasis.- J. Natl. Cancer Inst., 1972, v.48, N0.5, p.1441−1455.
- Harrington J.T., Stastny P. Macrophage migration from an agarose droplet: development of a micromethod for assay of delayed hypersensitivity.- J. Immunol., 1973, v.110, No.3, p.752−759.
- Haskill J.S. A micro-colony inhibition method for quantitation of tumor immunity.- J. Nat. Cancer Inst., 1973, v.51, p.1581−1588.
- Haskill J. S# ADCC effector cells in a murine adenocarcinoma. I. Evidence for blood-corne bone-marrow -derived monocytes.- Int. J. Cancer, 1977, v.20,No.3,p.432−440.
- Haskill J. S, Fett J.W. Possible evidence for antibody-dependent macrophage-mediated cytotoxicity directed against murine adenocarcinoma cells in vivo.- J. Immunology, 1976, v.117, No.5, p.1992−1999.
- Haskill J. S, Yamamura Y., Radov L. Host responses with solid tumors: non-thymus-derived specific cytotoxic cells within a murine mammary adenocarcinoma.- Int. J, Cancer, 1975, v.16, p.798−809.
- Haskill J.S., Yamamura J., Radov L., Parthenais E. Are peripheral and in situ tumor immunity related?- Ann.
- N.Y. Aced.Sci., 1976, v. 276, p. 373−379.
- Haskill J.S., Radov L.A., Yamamura J., Parthensia S., Korn J.H., Ritter F.L. Experimental solid tumors: The role of macrophages and lymphocytes as effector cells.- J. Retiluloendothel. Soc., 1976, v. 20, No.1, p. 233−241 *
- Hayflick L., The biology of human aging.-Advances in pathobiology, 1980, v. 7, p.80−99.
- Hellstrom K.E., Hellstrom J, Immunologic enhancement of tumor growth. In: Mechanisms of tumor immunity. N.Y., London, Sydney, Toronto, 1977, p. 147−174.
- Hellstrom J., Hellstrom K.E., Nepom J.T. Increased lymphocyte-mediated destruction of tumor cells in mic-rocytotoxicity assays seen after addition inhibitors of protein synthesis.-Int.J.Cancer, 1975, v. 16, No.5, p. 830−839.
- Henney C. Quantitation of the cell-mediated immune response. I. The number of cytolytically active mouse lymphoid cells induced by immunization with allogeneic mastocytoma cells. -J. Immunol., 1971? v. 107, p. 1558−1566.
- Henney G.S. Studies on the mechanism of the lymphocyte-mediated cytolysis. II. The use of various target cell markers to study cytolytic events. J.Immunol., 1973″ v. 110, p. 73−84″
- Henney C.S. Mechanisms of tumor cell destruction.- In: Mechanisms of tumor immunity. N.Y., London, Sydney, Toronto, 1977, p. 55−86.
- Henney C.S., Bubbers J.E. Antigen-T lymphocyte interaction: inhibition by cytochalasin B. J.Immunol., 1973, v.11, No. 1, p. 85−90.
- Heppner G*H. Neonatal thymectomy and mause mammary tumo-rigenesis. In: Immunity and tolerance in oncogenesis. Italy, 1970, p. 503−524.
- Heppner G.H., Stolbach L., Byrne M., Cummings F.J., McDonough E., Calabresi P. Cell-mediated and serum blocking reactivity to tumor antigens in patients with malignant melanoma. Int. J. Cancer, 1973, v. 11, No. 2, p.245−260.
- Herberman R.B., Holden H.T. Natural killer cells as antitumor effector cells. In: J, Natl. Cancer Inst., 1979, v. 62, No. 3, p. 441−445.
- Herberman R.B., Nunn M.E., Lavrin D.H. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. I. Distribution of reactivity and specificity.- Int. J. Cancer, 1975, v. 16, Ho. 2, p.21 6229.
- Hersey P., MacLennan J.C.M. Macrophage-dependent protection of tumor cells. Immunology, 1973, v. 24, No. 2, p. 385−393.
- Hewitt H.B., Blake E., Porter E.H. The effect of letha-lly irradiated cells on the transplantability of murine tumours. Br. J. Cancer, 1973, v. 28, No. 2, p.123−135.
- Hibbs J.В., Lambert L.H., Remington J.S. In vitro non -immunologic destruction of cells with abnormal growth characterized by adjuvant activated macrophages. -Proc. Soc. Exptl.Biol. Med., 1972, v. 139, No. 3, p.1049−1052.
- Hilgers J., Williams W.C., Myers B. Detection of antigens of the mouse mammary tumor (MTV) and murine leukemia cirus (MULV) in cells of cultures derived from mammary tumors of mice of several strains. Virology, 1971, v. 45, p. 470−483.
- Holden H.T., Haskill J.S., Kirchner H., Herberman R.l. Two functionally distinct anti-tumor effector cells isolated from primary murine sarcoma virus-induced tumors. J. Immunol., 1976, v. 117, No. 2, p.440−446.
- Holtermann O.A., Klein E., Gasale G. Selective cytotoxicity of peritoneal leucocytes for neoplastic cells.
- Cell Immunol., 1973, v. 9, No. 3, p. 339−352.
- Ihle J.N., Arthur L.O., Pine D.L. Autohenous immunity to mouse mammary tumor virus in mouse strains of high and low mammary tumor incidence. Cancer Res., 1976, v. 36, Noл 8, p. 2840−2844.
- Imir Т., Saksela E., Makela 0. Two types of antibody dependent cell-mediated cytotoxicity, arming and sensitization. J. Immunol., 1976, v. 117, no. 5, p.1938−1942.
- Jones R.O. The in vitro effect of epithelial growth factor on rat organ cultures. Exptl. Cell Res., 1966, v. 43, p. 645−656.
- Irie R.P. Antigen cross-reactivity between primary spontaneous mouse mammary tumors and their transplantable ascites tumors. Cancer Res., 1971, v. 31, No. 11, p. 1682−1689.
- Irie R.P., Koyama K., Hino S. Relation between the tumor-specific antigen and cytological characteristics in mouse mammary tumors. J. Nat. Cancer Inst., 1970, v. 45, No. 3, p. 515−524.
- Jessup J.M., Cohen M.H., Tomaszewski M.M., Eelox E.L.
- Effects of murine tumors on delayed hypersensitivity to dinitrochlorobenzene. I. Description of energy caused by transplanted tumors.- J. Natl-Cancer Inst., 1976, v. 57, No. 5, p. 1077-Ю84.
- Johnson T.S., Hudson J.L., Feldman M.E., Irvin C. L, Immu-noprophylaxis and cytotoxic affector cells against EL-4 leukemia induced in syngeneic C57B1/6 mice by use of irradiated EL-4 cells.- J, Natl. Cancer Inst., 1975, v. 55, No. 3, p. 561−567.
- Jolley G.M., Royle M.D.P., Ormerod M.G. The destruction of allogeneic tumor cells by antibody and adherent cells from peritoneal cavities of mice.- Cell. Immunol., 1976, v. 22, No. 2, p. 262−270.
- Jones В., Penfold P. Allograft cytotoxicity: critical tole for adherent T cells in effector mechanism of the peritoneal population.- Cell Immunol., 1979, v. 46, p.259−274.
- Julius M.H., Simpson E., Herzenberg L.A. A rapid method for the isolation of functional thymus derived lymphocytes.- Europ. J. Immunol., 1973, v. 3, p. 645−649.
- Kay H.D., Bonnard G. D, West W.H., Herberman R.B. A functional comparison of human Fe-receptor-bearing lymphocytes active in natural cytotoxicity and antibody dependent cellular cytotoxicity. J. Immunol., 1977, v. 118, No. 6, p. 2058−2066.
- Kay M. Mechanism of removal of senescent cells by human macrophages. Proc. Nat.Acad. Sci, USA, 1975, v, 72, No, 9, p. 3521−3525.
- Kedar E, Landazuri M.O., Bonavida B, Cellular Immuno-adsorbents: a simplified technique for reparation of lymphoid populations, — J, Immunol., 1974, v. 112, No. 3, p. 1231−1242,
- Keisari J., Witz J.P. Degradation of cell-bound antibodies by tumor cells from C57B1/6 mice * J, Natl. Cancer Inst*, 1978, v, 61, No. 4, p. 1135−1141.
- Keller R. Cytostatic elimination of syngeneic rat tumor cells in vitro by nonspecifically activated macrophages. J. Exptl. Med., 1973, v. 138, No. 3, p. 625−644.
- Keller R. Susceptibility of normal and transformed cell lines to cytostatic and cytocidal effects exerted macrophages* J, Natl, Cancer Inst, 1976, v. 56, No. 2, p. 362−374.
- Keller R. Macrophage-mediated natural cytotoxicity against various target cells in vitro. I. Macrophages from diverse anatomical sites and different strains of rats and mice.-Br. J. Cancer, 1978, v. 37, No. 5, p. 732−741.
- Kiessling R., Klein E., Wigzell H, Natural killer cells in the mouse. I. Cytotoxic cells with specificity for mouse, Moloney leukemia cells. Eur. J. Immunol., 1975″ v. 5, No. 2, p. 112−117.
- Kiessling R., Petrany G., Klein G., Wigzell H. Non-T-cell resistance against a mouse Moloney lymphoma. Int. J. Cancer, 1976, v. 17, No. 2, p.275−281.
- Koo G.C., Jacobson J.В., Hemmerling G.J., Hammerling U. Antigenic profile of murine natural killer cells.-J.Immunol., 1980, v. 125, No. 3, p. 1003−1006.
- Koren H, S., Amos D.B., Kim j. b# Natural killing and antibody-dependent cellular cytotoxicity are independent immune functions in the Minnesota miniature swine. Proc. natl.Acad.Sci. USA, 1978, v, 75, No. 10, p.5127−5131.
- Koren H.S., Ax W., Preund-Moelbert E. Morphological observations on the contact-induced lysis of target cells. Europ. J. Immunol., 1973, v. 3, Ho. 1, p.32−37.
- Kovithavongs Т., Rice G., Thong K.L., Dossetor J*B. Effector cell activity in antibody mediated cell dependent immune lysis. II. Evidence for different populations of effector cells for different targets. Cell Immunol., 1975, v. 18, p. 167−175.
- Lagrange P.H., Thickstun P.M. In vivo antitumor activity of various forms of delayed-type hypersensitivity in mice* J.Natl.Cancer Inst., 1979, v, 62, No.2, p.429−436.
- Lamon E.W., Hale Р", Whitten H, D, Antibody-dependent, cell-mediated cytotoxicity with autochthonous lymphocytes and sera after infection with Moloney sarcoma virus. -J. Natl. Cancer Inst., 1976, v.56, No. 2, p.349−355.
- Lamon E.W., Wigzell H., Klein E., Anderson В., Skurzak H.M. The lymphocyte response to primary Molong sarcoma virus tumors in BALB/c mice. -J, Exptl.Med., 1973, v.137, No. 6, p. 1472−1493.
- В" Characterization of cytotoxic effector cells in the mouse mammary tumor system" J. Immunol*, 1975, v.114, No. 1, p.24−29.
- Larizza L., Tenchini M.L., Mottura A,., DeCarli L., Colom-bi M., Barlati S. Expression of transformation markers and suppression of tumorigenicity in human cell hybrids.-Eur. J. Cancer Clin.Oncol., 1982, v. 18, No. 9, p.845−851.
- Lausch R.N., Rapp P. Concomitant immunity in hamsters bearing DMA-induced tumor transplants.-Int.J.Cancer, 1969, v. 4, No. 2, p.226−231.
- Laux D.C., Moody C.E., Parker В., Tunticharoen M. A comparison of the role of protein synthesis in cell-mediated cytotoxic reactions. Cell Immunol", 1978, v. 39, No. 2, p. 366−373.
- Larvin D.H., Blair P.В., Weiss D.W. Immunology of spontaneous mammary carcinomas in mice. III. Immunogenicitу of C3H prenocoplastic hyperplastic alveolar nodules in C3H hosts,-Cancer Res., 1966, v.26, No. 2, p.293−304.
- Lavrovsky V.A., Viksler V.Kh. Natural killer activity of Wistar rat spleen cells: blocking effect of homologous sera. Immunology, 1980(a), v.41, p.
- Lavrovsky V.A., Viksler V.Kh. Possible mechanism of target cell resistance in antibody-dependent cellular cytotoxicity. Eur. J. Immunol., 1980, v.10, p.483−486.
- Lavrovsky V.A., Viksler V.Kh. Immunologic properties of malygnant and nonmalignant sublines of L cells. -Cancer Res., 1980, v.40, p.
- Lesley L", Hyman R, Dennert G. Effect of antigen density on complement-mediated lysis, T-cell-mediated killing and antigen modulation, J.Nat.Cancer Inst., 1974, v.53, No. 6, p. 1759−1765.
- Levi-Montalcini R, Angeletti P.U. Nerve growth factor.-Physiol.Rev, 1968, v.48, p. 534−554,
- Loewenstein W. R, Junctional intercellular communication and the control of growth. -Biochim et Biophys. acta, 1979, v. 560, p.1−65,
- Lohmann-Matthes M., Domzing W., Taskov H. Antibody-dependent cellular cytotoxicity against tumor cells. I. Cultivated bone marrow-derived macrophages kill tumor targets.-Eur.J. Immunol., 1979, v.9, No, 4, p.261−266.
- Loveren H.V., Otter W. D, Macrophages in solid tumors.I. Immunologically specific effector cells,-J.Natl.Cancer Inst., 1974, v, 53, No. 4, p.1057−1060.
- Lubens R.G., Gard S.Z., Soderberg-Warner M., Stiehm E. R, Lectin-dependent T-lymphocyte and natural killer cytotoxic deficiencies in human newborns.-Cell Immunol., 1982, — 262 -v.74, No.1, p.40−53
- Mantovani A. Effects on in vitro tumor growth of murine macrophages isolated from sarcoma lines differing in im-munogenecity and metastasizing capacity. Int.J. Cancer, 1978, v.22, No. 6, p.741−746.
- Mantovani A., Jerrells T.R., Dean J.H., Herberman B.B. Cytolytic and cytostatic activity on tumor calls of circulating human monocytes. Int. J. Cancer, 1979, v.23, No. 1, p. 18−27.
- Marx J. Natural killer cells help detend the body. Immu-nologists take a new look at immune surveillance and interferon action in the light of natural killer activity. Science, 1980, v.210, No. 4470, p.624−626.
- Mathe G. Immunological approaches of leukemia treatment. -Ann. Inst. Pasteur, 1972, v.122, N0.4, p.855−881.
- Matter A. Microcinematographic and electron microscopic analysis of target cell lysis induced by cytotoxic T lymphocytes. Immunology, 1979, v.36, No. 2, p.179−190.
- Miller S.C., Hay E.D., Codington J.P. Ultrastructuraland histochemical differences in cell surface properties of strain-specific and nonstrain-specific ТАЗ adenocarcinoma cells. J. Cell Biol., 1977, v. 72, No. 3, p.511−529.
- Minato N., Bloom B.R., Jones C., Holland J., Reid l.M. Mechanism of rejection of virus persistently infected tumor cells by athymic nude mice. J. Exptl. Med., 1979, v. 149, No. 5, p. 1117−1138.
- Moller E. Antogeneitic effects of humoral isoantibodies on the in vitro cytotoxicity of immune lymphoid cells.-J. Exper.Med., 1965, v. 122, p, 11−23.
- Moller E., Moller G. Quantitative studies of the sensitivity of normal and neoplastic mouse cells to the cytotoxic action of isoantibodies. J.Exptl.Med., 1962, v.11 5, p. 527−533.
- Moudal S., Embleton M. J, Marquardt H., Heidelberger Ch. Production of variants of decreased malignancy and antigenicity from clones transformed in vitro by methylcho-lantrene• Int. J. Cancer, 1971, v. 8, No. 3, p.410−420.
- Masaki Ohsugi. In vitro studies on the inhibitory effect of lymphoid cells. II. Antitumor activity of lymphoid cells from spontaneous mammary tumor-bearing mice on the autochthonous primary culture tumor cells. Acta Med*
- Okayama, 1971, v. 25, p.229−235.315"Muller M, Zotter S. Spontaneous immunity to mammary-tumour virus (MTV)-associated antigens in mice and its influence on syngeneic mammary-tumour growth. Europ. J. Cancer, 1972, v. 8, No. 5, p.495−500.
- Muller M, Zotter S, Mammary tumour virus (MTV) infection of СБА / Bin mice involving production of antibodies to MTV, J. Natl. Cancer Inst., 1973, v. 50, No. 3, p.713−717.
- Mintz В., Slemmer G, Gene control of neoplasma. I" Genoty-pic mosaicism in normal and preneoplastic mammary glands of allophenic mice. J, Nat. Cancer Inst., 1969, v. 43, p.87−95.
- Moore D.H., Hollen J.A., Charney J. Biologic characteristics of some mouse mammary tumour viruses. J. Natl. Cancer Inst., 1976, v. 57, No. 4, p.889−896.
- Miggiano V", North M., Buder A, Pink J.R.L, Genetic control of the response of chicken leukocytes to a T-cell mitogen, Nature, 1976, v.263, No. 5572, p.61−63.
- Nandi S., McGrath C.M. Mammary neoplasma in mice. Inr Advances in Cancer Re., N.Y. London, 1973, v. 17, p.353−414.
- Nathan C. F, Silverstein S.C., Brukner L.H., Cohn Z.A. Extracellular cytolysis by activated macrophages and granulocytes. II. Hydrogen peroxide as a mediator of cytotoxicity, J. Exptl" Med., 1979, v.149, No, 1, p.100−113.
- Nelson M., Nelson D. S, Macrophages and resistance to tumors, I. Inhibition of delayed-type hypersensitivity reactions by tumor cells and by soluble products affecting macrophages. Immunology, 1978, v. 34, No, 2, p, 277−290.
- Nemoto Т., Han Т., Minovada J., Angjur V., Camberlain A.,
- Dao T.L. Cell-mediated immune status of breast cancer patients: evaluation by skin tests, lymphocyte stimulation and counts of rosette-forming cells" J. Natl. Cancer Inst., 1974, v. 53, No. 3, p. 641−645.
- Nicolson G.L. Trans-membrane control of the receptors on normal and tumor cells. II. Surface changes associated with transformation and malignancy. Biochim. et Biophys. Acta, 1976, v. 458, p.1−72.
- North R.J., Kirstein D.P. T-cell mediated concomittant immunity to syngeneic tumors. I. Activated macrophages as the expressors of nonspecific immunity to unrelated tumors and bacteria.1 parasites. J. Exptl. Med., 1977, v. 145, No. 2, p. 275−292.
- North R.J., Kirstein D.P., Tuttle R.L. Subversion of host defense mechanisms by murine tumors. I. A circulating factor that suppresses macrophage-mediated resistance to infection. J. Exptl. Med., 1976, v. 143, p.559−573
- North R.J., Kirstein D.P., Tuttle R.L. Subversion of host defense mechanisms by murine tumors. II. Counting influence of concomitant antitumor immunity. J. Exptl. Med.1976, v, 143, p. 574−584*
- Nowotny A, Butler R., Grohman J., Keebler C. Dual effects of tumor antigens: induction of tumor resistance or tumor growth enhancement* Ann* N.Y. Acad. Sci., 1976, v. 276, p. 106−123.
- Nunn M.E., Herberman R.B., Holden H. T, Natural cell-mediated cytotoxicity in mice against non-lymphoid tumor cells and some normal cells. Int. J. Cancer, 1977, v. 20, No. 3, p. 381−387.
- Oehler J.R., Lindsay L.R., Nunn M.E., Nerberman R.B. Natural cell-mediated cytotoxicity in rats. I. Tissue and strain distribution and demonstration of a membrane receptor for the Pc portion of IgM, Int. J. Cancer, 1978, v. 21, No, 2, p. 204−209.
- Ojo E., Haller 0., Kimura A., Wigzell H. An analysis of conditions allowing Corynebacterium Parvum to cause either augmentation or inhibition of natural killer cell activity against tumor cells in mice. Int. J. Cancer, 1978, v. 21, No. 4, p. 444−452.
- Ohanian S.H., Borsos Т", Rapp H.J. Lysis of tumor cellsby antibody and complement. I. Lack of correlation between antigen content and lytic susceptibility. J, Natl. Cancer Inst., 1973, v. 50, No. 5, p. 1313−1320.
- Oho S., Natsu-ume S., Migita S. Alternation of cell-surface antigenicity of the mouse plasmacytoma. I. Immunologic characterization of surface antigens masked during successive transplantations, J, Natl. Cancer Inst., 1975, v. 55, No. 3, p. 569−577.
- Otter W.D., Runhaar B. A, Ruitenbeek A., Dullens H.P.J, Site-depemdent differences in rejection of tumor cells with and without preimmunization. Eur. J. Immunol., 1974, v, 4, No. 6, p.444−446,347* Padarathsingh M. L, McCoy J.L., Dean J.H., Lewis D.D.,
- Northing J.W., Law L. W, Examination of general and tumour specific cell-mediated immune responses in mice bearing progressively growing plasmacytomas. J, Natl. Cancer Inst., 1977, v. 58, No. 6, p.1701−1707.
- Phillips W.H., Ortaldo J.R., Herberman R.B. Selective depletion of human natural killer cells on monolayers of target cells. J. Immunol., 198Q, v. 125, No. 5, p. 23 222 327.
- Pierotti M. A, Colnaghi M. J, Natural antibodies directed against murine lymphosarcoma cells: variability of level in individual mice. Int. J. Cancer, 1976, v. 18, No. 2, p.223−229.
- Pierotti M.A., Colnaghi M, J, Natural antibodies directed against murine lymphosarcoma cells. J. Natl. Cancer Ins, 1975, v, 55, No, 4, p.945−949.
- Piper C.E., Mclvor K.L. Alloimmune peritoneal macrophages as specific effector cells: characterization of specific macrophage-cytotoxin, Cell Immunol., 1975, v, 17, No. 2, p. 423−430.
- Plata P., Sordat B, Murine sarcoma virus (MSV)-induced tumors in mice, I, Distribution of MSV-immune cytolitic
- T-lymphocytes in vivo. Int. J, Cancer, 1977, v. 19, No, 2, p.205−211.
- Pollack S.B., Hallenbeck L#A, In vivo reduction of NK activity with anti-NK1 serum: direct role of NK cells in tumor clearance. Int. J, Cancer, 1982, V. 29, No. 2, p. 203−207.
- Pollack S.B., Nelson K., Grausz J.D. Separation of effector cell mediating antibody-dependent cellular cytotoxicity (ADC) to erytrocyte target from those mediating ADC to tumor targets. J. Immunol., 1976, v, 116, No. 4, p. 944−946.
- Poulakos L., Schenken L.L., Hagemann R.P., Rurholt D.R., Lesher S. Control of local tumor growth with combinedfractionated radiotherapeutic and chemotherapeutic regimes. J. Natl. Cancer Inst., 1975, v. 54, No. 5, p.1103−1105.
- Poupon M.P., Kolb J.P., Lespinats G. Evidence for splenic suppressor cells in C3H/He, T-cell-deprived C3H/He, and nude mice bearing a 3-methylcholantrene-induced fibrosarcoma. J. Natl. Cancer Inst., 1976, v. 57, No, 2, p. 1241−1247.
- Prehn T, R. A clonal selection theory of chemical carcinogenesis. J, Nat. Cancer Inst., 1964, v, 32, p, 1−17.
- Prehn R, T, Immunostimulation of the lymphodependent phase of neoplastic growth. J, Natl, Cane er Inst, 1977, v., 59, No, 4, p. 1043−1049.
- Prehn R.T. Immunological basis for differences in susceptibility to hydrocarbon oncogenesis among mice of a single genotype. Int. Cancer, 1979, v, 24, No, 6, p, 789−791*
- Quindlen E., Wood W, Komblith P.L. Mechanisms of humoral cytotoxicity testings: the role of rabbit serum, xenoantibody and human IgM, J, Immunol., 1977, v. 118, No. 5, p. 1836−1842.
- Ramos A, Zavala P., Hoecker G. Immune response to glutaraldehyde-treated cells. I, Dissociation of immunological memory and antibody production, Immunology, 1979, v. 36, Wo. 4, p. 775−780.
- Raz A., Bucana C. The redistribution of membrane surface immunoglobulin induces the rearrangement of some membrane integral proteins, Biochim. Biophys. Acta, 1980, v.597, p. 615−621.
- Reed W.P., Lucas Z. J, Cytotoxic activity of lymphocytes, V, Role of soluble toxin in macrophage-inhibited cultures of tumor cells, J, Immunol., 1975, v. 115, No. 2, p. 395−404.
- Riccardi C, Puccetti P., Santoni A., Herberman R. B, Rapid in vivo of mouse natural killer cell activity.-J.Natl, Inst., 1979, v, 63, No, 4, p.1041−1045.
- Richters A, Shervin R.P. Human breast cancer and auto-chthomous lymph node cell responses: a tissue culture and ultrastructural study, Cancer, 1974, v. 34, No. 2, p. 328−337.
- Richters A., Schervin R. P, Richters V. The lymphocyte and human lung cancers. Cancer Res., 1971, v, 31″ No.3, p. 214−222,
- Revesz L. Effect of tumour cells killed by X-rays upon the growth of admixed viable cells. Nature, 1957, v. 178, p. 1391−1395.
- Robbins J.C., Nicolson G. L, Surface of normal and transformed cells. Cancer, 1975, No. 4,, p. 3−54.
- Roberts P.J., Hayry P. Effector mechanisms in allograft rejection. II. Density, electrophoresis and size fraction of allograft-infiltrating cells demonstrating several classes of killer cells. Cell Immunol., 1977, v. 30, No. 2, p.236−253.
- Roder J.C., Lohman-Matthes M., Domzig W., Kiesseling R., Haller 0. A functional comparison of tumor cell killing by activated macrophages and natural cells. Eur. J.Immunol., 1979, v. 9, No. 4, p.283−288.
- Roder J.C., Lohman-Matthes M, Domzig W, Wigzell H. The beige mutation in the mouse. II. Selectivity of the natural killer (NK) cell defect. J. Immunol., 1979, v. 123, No. 5, p.2174−2181.
- Roder J.C., Rosen A., Penyo E.M., Troy E.A. Target-effector interaction in the natural killer cell system: isolation of target structures. Proc. Natl. Acad.Sci. USA, 1979, v. 76, No. 3, p.1405−1409.
- Rosenau W. and Moon H.D. Lysis of homologous cells by: sensitized lymphocytes in tissue culture. J.Nat. Cancer Inst., 1961, v. 27, p.471−483.
- Rosenberg E.B., McCoy J.L., Green S.S., Donnelly P.C.,
- Guinea pig lymphotoxin (LT). I. In vitro studies of LT produced in response to antigen-stimulation of lympho- 274 cytes, — J. Immunol., 1973, v.110, No. б, р, 1б23−1б29.
- Rosenberg S.A., Plocinik B.A., Rogentine G.N. Unmasking of human lymphoid cell heteroantigens by neuraminidase treatment.- J. Nat. Cancer Inst., 1972, v.48, No.5, p.1271−1276.
- Roubinian J.R., Lane M., Slomich M., Blair P.B. Stimulation of immune mechanisms against mammary tumors by incomplete T cell depletion.- J.Immunol., 1976, v.117,1. No. 5, p.1767−1773.
- Rudczynski А.В., Mortensen R.F. Suppressor cells in mice with murine mammary tumor virus-induced mammary tumors. I. Inhibition of mitogen-induced lymphocyte stimulation.- J. Natl. Cancer Inst., 1978, v, 60, No.1, p. 205−211 .
- Russell S, W,5 Doe Y/.F., Mcintosh A.T. Functional characterization of a stable, noncytolytic stage of macrophage activation in tumors.- J. Exptl. Med., 1977, v.146, No, 6, p, 1511−1520.
- Ryzewska A.G., Dabrowska B. K, Lymphokine in the rat. I. Evidence that lymphotoxin activity involves both cytotoxic and stimulating factors.- Immunology, 1976, v.31, No.5, p.677−687.
- Sanderson C.J., Glauert A. M, The mechanism of T-cell mediated cytotoxicity, VI. T-cell projections and their role in target cell killing, — Immunology, 1979, v.36,p.119−129.
- Sanford K, K, Evans V"J, A quest for the mechanism of «spontaneous» malignant transformation in culture with associated advances in culture technology.- J, Natl. Cancer Inst, 1982, v.68, N0.6, p.895−913.
- Sanford B.H., Kohn N, J., Baly J.J., Soo S. F, Long-term spontaneous tumor incidence in neonatally thymectomized mice. J, Immunol., 1973, v. 110, No. 5, p.1437−1439.
- Sanford K. K, Spontaneous neoplastic transformation of cells in vitro: some factors and theories, Nat. Cancer Inst. Monogr., 1967, v. 26, p.387−418.
- Sanford K.K. Biologic manifestations of oncogenesis in vitro: a critique. J. Natl. Cancer Inst., 1974, v. 53, No. 5, p. 1481−1485.
- Santoli D., Trinchieri G., Zmijewski C.M., Koprowski H. HLA related control of spontaneous and antibody-dependent cell-mediated cytotoxic activity in humans. — J, Immunol, 1976, v. 117, No. 3, P.765−770,
- Schaaf-Lafontaine N. Separation of lymphoid cells with a suppressor effect on the activity of cytotoxic cells in vitro during the growth of syngeneic tumour, Int. J, Can-cer, 1978, v. 21, No, 3, p.329−333.
- Schechter В., Feldman Ы. Hydrocortisone affects tumor growth by eliminating precursors of suppressor cells. -J, Immunol., 1977, v. 119, No. 5, p.1563−1568.
- Schik В., Berke G. Is the presence of serologically defined target cell antigens sufficient for binding of cytotoxic T-lymphocytes? Transplantation, 1978, v. 26, No, 1, p.14−18.
- Shib T, Yata J, Okada H, Nonspecific activation of complement by leukemic cells. Int. J. Cancer, 1978, v. 22, No. 4, p.422−425.
- Schirrmacher V., Shantz G., Clauer K., Komitowski D, Zim-mermann H. P, Lohmann-Matthes M, L, Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice.
- Tumor invasiveness in vitro and metastasis formation in vivo. Int. J, Cancer, 1979, v. 23, No. 2, p, 233−244.
- Schlager S. J, Ohanian S. H, Borsos T. Correlation between the ability of tumor cells to resist humoral immune attack and their ability by synthesized lipid. J, Immunol-, 1978 (b), v, 120, No. 2, p.463−471.
- Schneider E.L., Stanbridge E, Y, Epstein C.J. Incorporation of H-uridine and H-uracil into RNA. A simple technique for the detection of mycoplasma contamination of cultured cells. Exptl, Cell.Res., 1974, v.84, No.1−2, p.311−318.
- Schumm D.E., Billmire D.F. Progressive loss of in vitro immune response with tumor growth. Cell Immunol,", 1976, v. 24, No, 2, p.348−354.
- Scornik J.C., Cosenza H. Antibody-dependent cell-mediated cytotoxicity. III. Two functionally different effector cells, J. Immunol., 1974, v, 113, No. 5, p.1527−1532.
- Scott M.T. Cocynebacteriurn parvum asa therapeutic antitumor agent in mice. I. Systemic effects from intravenous injection. J, Natl. Cancer Inst., 1974, v. 53, No. 3, p.855−860.
- Senik A., Gresser J., Maury C., Gidlund M, Orn A., Wigzell H, Enhancement interferon of natural killer cell activity in mice. Cell Immunol., 1979, v. 44, No. 1, p. 186−200.
- Shellam G. R, Hogg N. Gross-virus-induced lymphoma in rat, IV, Cytotoxic cell in normal rats, Int. J, Cancer, 1977, v. 19, p.212−224.
- Sigel M. M, Lopez G., Ortiz-muniz. In vitro immune responses to rival and tumor antigens in murine breast cancer. -Cancer Res., 1976, v. 36, p.748−752.
- Sinclair N.R., Lees R.K., Pagan G., Birnbaum A. Regulation of the immune response. VIII, Characteristics of in vitro cell-mediated immune response. Cell Immunol, 1975, v. 16, No, 2, p.330−347.
- Sklaroff D.M., De Courcy S.J., Specter S., Friedman H, Suppressed development of mammary tumorigenesis in R III mice treated neonatally with BCG (40 118). Proc. Soc. Exptl, Biol. Med., 1978, v, 158, No. 2, p.235−237.
- Sluyser M., Nie R.V. Estrogen receptor content and hormone responsive growth of mouse mammary tumors, — Cancer Res., 1974, v. 34, p. 3253−3257,
- Smets L. A, Cell transformation as model for tumor induction and neoplastic growth, Biochim. et Biophys. Acta, 1980, v, 605, p.93−111 ,
- Small M, Trainin N, Separation of populations of sensitized lymphoid cells into fractions inhibiting and fractionsenhancing syngeneic tumor growth in vivo" — J. Immunol",, 1976, v.117, No.1, p.292−297″
- Snell G.D., Stimpfling J.H. Genetics of tissue transplantation.- In — Biology of the laboratory mouse. U.Y.-London, 1966, p.457−491.
- Sparck J.V. The function of the immune response in tumour growth and genetical regulation.- Acta Path. Microbiol. Scand., 1969, v.77, p.1−23.
- Sparks P.O., Breeding J.H. Tumor regression and enhancement resulting from immunotherapy with Bacillus Calmette-Guerin and neuraminidase.- Cancer Res., 1974, v.34, p. 3262−3269.
- Squartini P., Olivi M, Bolis G.B. Mouse strain and breeding stimulation as factors influencing the effect of thymectomy on mammary tumorigenesis.- Cancer Res., 1970, v.30, p.2069−2072.
- Sternova E., Cech K., Nouza K., Pekarek J., Krejci J. Cytotoxicity of normal rabbit serum for chicken lymphoid cells. I. Localization of the activity.- Immunology, 1976, v.30, Ho.6, p.925−927.
- Stevenson M. M, Meltzer M.S. Depressed chemotactic responses in vitro of peritoneal macrophages from tumor-bearing mice.- J. ITatl. Cancer Inst., 1976, v.57, Ko.4, p.847−852.
- Stulting R. D, and Berke G. Nature of lymphocyte-tumor interaction. A general method for cellular immunoabsorp-tion, — J. Exptl. Med., 1973, v.137, p.932−942.
- Stulting R.D., Todd R.F., Amos D.B. Lymphocyte-mediated cytolysis of allogeneic tumor cell in vitro. II. Binding of cytotoxic lymphocytes to formaldehyde-fixed target cells.- Cell Immunol., 1975, v.20, p.54−63.
- Stulting R.D., Todd R.F., Gooding L.R. Susceptibilityof anti-H-2-capping target cells to humoral and T-lympho-cyte-mediated lysis.- Transplantation, 1976, v.21, No.1, p.71−73.
- Stutman 0. Immunodepression and malignancy.- Advances in Cancer Res., 1975, v.22, p.261−422.
- Stutman 0. Correlation of in vitro and in vivo studiesof antigens relevant to the control of murine breast cancer, — Cancer Res, 1976, v.36, p.739−747.
- Stutman 0. Immunodeficiency and Cancer.- In: Mechanisms of tumor immunity, N.Y., London, Sydney, Toronto, 1977, p.27−54.
- Stutman 0., Paige C.J., Figarella E.F. Natural cytotoxic cells against solid tumors in mice. I, Strain and age distribution and target cell susceptibility.- J. Immunol., 1978, v.121, No.5, p.1819−1826,
- Stutman 0, Shen F., Boyse E, A. Ly phenotype of T-cells cytotoxic for syngeneic mouse mammary tumors: evidence for T cell interactions.- Proc. Natl. Acad, Sci, USA, 1977, v.74, No.12, p.5667−5671.
- Svennevig J., Svaar H. Content and distribution of macrophage and lymphocytes in solid malignant human turnours.-Inst. J. Cancer, 1979, v.24, No, 6, p. 754−758.
- Szent-Gyorgyi A. Cell division and cancer.- Science, 1965, v.143, No, 3679, p.34−37.
- Takasugi M, Akira D, Role of antibodies in the specificity of natural cell-mediated cytotoKicity, — J. Natl, Cancer Inst., 1979, v.62, No, 6, p.1361−1365.
- Takasugi M., Klein E, Amiroassay for cell-mediated immunity .- Transplantation, 1970, v, 9, p.219−227.
- Takasugi M., Mickey M. R, Terasaki P.J. Studies on specificity of cell-mediated immunity to humor tumors.- J. Natl, Cancer Inst., 1974, v.53, No.6, p.1527−1538,
- Takasugi M., Ramseyer A., Takasugi J. Decline of natural nonselective cell-mediated cytotoxicity in patients with tumor progression.- Cancer Res, 1977, v.37, No.2,p.413−418.
- Takasugi J., Koide Y., Takasugi M, Reconstitution of natural cell-mediated cytotoxicity with specific antibodies.- Eur. J, Immunol., 1977, v.7, No.12, p.887−892.
- Takei P., Levy J.G., Kilburn D, G, In vitro induction of cytotoxicity against syngeneic mastocytoma and its suppression by spleen and thymus cells- from tumor-bearing mice.- J.Immunol., 1976, v.116, No.2, p.288−293.
- Takeichi N., Boone C.W., Holden H.T., Herberman R.B. Immunological study of two stocks of Moloney sarcoma virus producing regressor and progressor tumors in C57B1/6 mice Int. J. Cancer, 1978, v.21, No.1, p.78−84.
- Tamiyama Т., Holden H. T, Cytolytic activity of macrophages isolated from primary murine sarcoma virus (MSV) induced tumors.- Int. J. Cancer, 1979, v.24, No.2, p, 151−160.
- Taylor G., Kumar S., Bremchley P., Wilson P., Costello В., Shaw G.H. Immunosurveillance in pre-malignant occupational bladder disease.- Int. J. Cancer, 1979, v.23, No.4,p.487−493.
- Tevethia S.S., McMillan V.L., Kaplan P.M., Bushong S.C. Variation in immunosensitivity of SV-40-transformed hamster cells.- J. Immunol., 1971, v.106, No, 5, p.1295−1300.
- Theofilopoulos A.N., Perrin L.H. Lysis of human cultured lymphoblastoid cells by cell-induced activation of the properdin pathway.- Science, 1977, v.195, No, 4281, p. 878−880.
- Thomas W. R, Aw E. J, Papadimitrion J.M., Simons P, J.
- Ting C.C. Humoral regulation of cell-mediated immunity to syngeneic tumor.- Cancer Res., 1976, v.36, No.10, p. 3695−3701.
- Ting C.C., Rodrignes D., Bushav G.S., Herberman R.B. Cell mediated immunity to Friend virus-induced leukemia. II. Characteristics of primary cell mediated cytotoxic response.- J. Immunol., 1976, v.116, No. 1, p. 236−243″
- Ting C.C., Shin G., Rodrignes D., Herberman R.B. Cell-mediated immunity to Friend virus-induced leukemia.-Cancer Res., 1974, v.34, No.7, p.1684−1687.
- Ting C. C*, Tsai S.C., Rogers M.J. Host control of tumor growth.- Science, 1977, v.197, No.4303, p.571−573.
- Todd R.T., Stutling R.D., Amos D"B. Lymphocyte-r.ediated cytolysis of allogeneic tumor cells in vitro. I. Search for target antigens in subvellular fractions.- Cell Immunol., 1975, v.18, No.2, p.304−323.
- Tracey D., Wolfe S., Durdik J., Henney C. BCG-inducedmurine effector cells. I. Cytolytic activity in peritoneal exudates: an early response to BCG.- J,. Immunol., 1977, v.119, No.3, p.1145−1151.
- Tsoi M., Weiser R.S. Mechanisms of immunity to sarcoma I allografts in the C57B1 mouse. I. Passive transfer studies with immune peritoneal macrophages in X-irradi-ated hosts.- J. Natl. Cancer Inst., 1968, v.40, No.1,p. 23−30.
- Tufveson G,, Riesenfeld J., Ronnblom L., Hedman A., Aim G.V. Natural cell-mediated immunity to lymphoma cells. I. Characteristics of effector cells in a cyto-stasis assay in vitro.- J. Natl. Cancer Inst., 1977, v.59, No.5, p.1491−1497.
- Vaage J. Concomitant immunity and specific depressionof immunity by residual or rejected syngeneic tumor tissue*- Cancer Res., 1971, v.31, No.11, p.1655−1662.
- Vaage V. Specific desensitization of resistance against a syngeneic methylcholanthrene-induced sarcoma in C3Hf mice*- Cancer Res., 1972, v.32, No. 2, p.193−199.
- Vaage J" A survey of the growth characteristics of and the host reactions to one hundred C3H/He mammary carcinomas. Cancer Res., 1978, v.38, No.2, p.331−338.
- Vaage J., Medina D, Virus oncogenesis and tumor immuno-genicity in mouse mammary tumor system.- Cancer Res., 1974, v.34, N0.6, p.1319−1324. 470″ Vanderputte M. Immunosuppression and Cancer.- Ann.Inst. Pasteur, 1972, N0.4, p.677−683.
- Vanky P., Stjernsward J., Nilsone U., Sundblad R, Differences in the tumor-associated reactivity of blood lymphocytes and tumor-draining lymphnode cells sarcoma patients.- J. Natl. Cancer Inst., 1973, v., 51, No.1, p.17−24.
- Vazquez A., Senik A., Pridman W.H., Neauport-Sautes C. Public H-2 specificities are target determinants for alloreactive cytotoxic T lymphocytes.- J. Immunogenet., 1980, No.1, p.107−122.473″ Veit B.C., Jones J. M, Miller G.A., Feldman J. D,
- Genetic association of the humoral and cellular immune responses of rats to Moloney sarcomas.- Int. J. Cancer, 1977, v.19, No.1, p.97−106,
- Vessella R. L, Gormus B. J, Lange R.H., Lange R.H.,
- Weinhold K.J., Miller D.A., V/heelock E. P, The tumor dormant state. Comparison of L5178Y cells used to establish dormancy with those that emerge after its termination, J, Exptl, Med, 1979 (b), v.149, No, 3, p.745−757.
- Welsh R. M, Mouse natural killer cells: induction specificity and function, J. Immunol., 1−78, v. 121, No. 5, p.1631−1635.
- Wernet D., Lilly P. Separation of T-cell killer function and T-cell helper function in B10. A (5R) mice immunized with B10 cells. Transplant to-day, 1975, v. 3, p.135−137″
- Wiener P., Klein G., Harris H. The analysis of malignancy by cell fusion, IV, Hybrids between tumours cells and a malignant L cell derivative. J, Cell Sci", 1973, v. 12, No. 1, p.253−261.
- Wiener P., Klein G., Harris H. The analysis of malignantby cell fusion, VI, Hybrids between different tumour cells, J, Cell Sci., 1974, v, 16 m, No. 1, p.189−198,
- Willebrand E, Soots A, Hayry P. Insitu effector mechanisms in rat kidney allograft parenchyma., Cell immunol, 1979 (a), v. 46, No. 2, p.309−326.
- Wood G.W., Gollahon K.A. T-lymphocytes and macrophages in primary murine fibrosarcomas at different stages in their progression, Cancer Res., 1978, v, 38, No. 7, p. 1857−1865.
- Sci, USA, 1975, v. 72, No. 7, p.2780−2784. 497* Zarling J*M., Tevethia S.S. Transplantation immunity to Simian virus 40-transformed cells in tumor-bearing mice.
- Development of cellular immunity to Simian virus 40 tumor-specific transplantation antigens during tumorige-nesis by transplanted cells. J. Nat. Cancer Inst., 1973, v. 50, No. 1, p.137−147.
- Zarling J.M., Tevethia S.S. Transplantation immunity to
- Zighelboim J., Bonavida В., Faheg J.L. Evidence for several cell populations active in antibody-dependent cellular cytotoxicity. J, Immunol., 1973, v.111, No. 6, p. 1737−1742.
- Zighelboim J., Bonavida В., Fahey J. Antibody-mediatedin vivo suppression of EL-4 leukemia in a syngeneic host. J.Natl. Cancer Inst., 1974, v. 52, No. 3, p.879−881.
- Yamamura Y. Immunologic responses to a rurine mammary adenocarcinoma. II. Monocyte effector activation by humoral factors. Int. J. Cancer, 1977, v. 19, No. 5, p. 717−724.
- Yamamura J., Virella G., Haskill J.S. Immunologic responses to a murine mammary adenocarcinoma. I. Passive transfer of immunity by sera from tumor-bearing mice. Int. J, Cancer, 1977, v. 19, No. 5, p.707−716.
- Yefenot E., Klein G. Antibody-induced redistribution of normal and tumor associated surface antigens. Exptl. Cell Res., 1974, v. 88, No. 2, p.217−224.
- Youn J.R., Santillana M, Jue G., Barski G. Virus expression in different tissues of normal and tumor-bearing mice inoculated with amurine leukemia virus" Int. J. Cancer, 1977, v. 20, p.792−797.
- Yutoku M., Fuji H, Grossberg A. L, Pressman D. An experimental model for evaluation of factors in tumor escape from immunological attack, Cancer Res., 1975, v. 35, No, 3, p.734−739.